REMEDI Inc.
Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.
As of 2026-10-10, REMEDI Inc. has 15 Korean MFDS device approvals, 4 US FDA clearances/approvals, 10 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- KA6Portable X-ray imaging device for chest imaging
- GR100Portable dental X-ray imaging device
- XCAM6Portable medical X-ray imaging device (up to 90kV)
- XCAM10Portable medical X-ray imaging device (up to 100kV)
- RIXB100X-ray inspection equipment for detecting internal structure and defects in secondary batteries
- High-voltage generatorPower supply device for X-ray generation
- Compact X-ray tubeCore component for X-ray generation
Regulatory approvals
data.go.kr · openFDA15 Korean MFDS device approvals · 2015–2026 / 4 US FDA 510(k) · 2020–2025
- MFDSX-ray system, diagnostic, portable, analogue2026-06-05Product approval · Class 2제인 26-4498 호
- MFDSX-ray system, diagnostic, portable, analogue2025-12-10Product approval · Class 2제인 25-5151 호
- MFDSX-ray system, diagnostic, portable, analogue2025-08-29Product approval · Class 2제인 25-4811 호
- FDAREMEX Xcam62025-07-31
- MFDSMedical image, analog to digital transform, DR, CR2024-12-16Product approval · Class 2수인 24-670 호
- MFDSX-ray system, diagnostic, portable, analogue2024-07-24Product approval · Class 2제인 24-713 호
- FDAREMEX-GR1002024-05-13
- MFDSX-ray system, diagnostic, portable, analogue2021-11-08Product approval · Class 2제인 21-4947 호
- FDARemex KA62021-08-03
- MFDSX-ray system, diagnostic, portable, analogue2020-05-27Product approval · Class 2제인 20-4438 호
- MFDSX-ray system, diagnostic, portable, analogue2020-04-29Product approval · Class 2제인 20-4328 호
- FDAR-Sensor, R-Sensor2020-02-28
Show 7 more
- MFDSX-ray system, diagnostic, portable, analogue2019-09-26Product approval · Class 2제인 19-4809 호
- MFDSStomatoscope, video2019-02-07Product approval · Class 1제신 19-186 호
- MFDSMedical image, analog to digital transform, dental2018-12-14Product approval · Class 2제인 18-5061 호
- MFDSStomatoscope, video2018-02-01Product approval · Class 1제신 18-123 호
- MFDSDental x-ray system, panoramic/tomographic, digital2017-12-19Product approval · Class 2제인 17-4984 호
- MFDSX-ray system, diagnostic, portable, analogue2016-05-10Product approval · Class 2제인 16-4381 호
- MFDSDental x-ray system, general-purpose, intraoral, digital2015-06-09Product approval · Class 2제허 15-904 호
R&D and key agreements
Source: DART corporate disclosureRDX Tower (Real-time Digital X-ray Tower) · 수술용 영상장비(C-arm 대체) · 개발 중 · Combines a robotic detachable X-ray system with real-time imaging to reduce spatial interference and radiation exposure in surgical settings
Publications
PubMed · affiliation-matched- Diagnostic accuracy of an artificial intelligence-based osteoporosis screening system on portable chest radiographs.
Journal of thoracic disease · 2026-08 · Kim JH, Ahn SH, Lee R 외 3
- Task dependent early landing kinematics after return to sport in individuals with ACL reconstruction: a secondary analysis.
BMC musculoskeletal disorders · 2026-05 · Wang B, Wang Z, Cheng L
- RMAD1, a Novel Cell-Penetrating Peptide Derived from ADARB2: Preclinical Insights into Antigen Uptake and T Cell Activation.
International journal of biological sciences · 2026-01 · Lim C, Park C, Song EC 외 7
- Performance evaluation of deep learning-based osteoporosis diagnostic models with conventional chest X-ray in a clinical cohort.
Journal of thoracic disease · 2025-11 · Koo B, Roh Y, Shin G 외 5
- Comments on "ChatGPT's role in alleviating anxiety in total knee arthroplasty consent process: a randomized controlled trial pilot study".
International journal of surgery (London, England) · 2025-06 · Cai X, Wang B, Cheng L 외 1
- Letter to the Editor: Leptin Enhances M1 Macrophage Polarization and Impairs Tendon-Bone Healing in Rotator Cuff Repair: A Rat Model.
Clinical orthopaedics and related research · 2025-04 · Cai X, Wang B, Cheng L 외 1
- Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society · 2025-02 · Koo J, Shin Y, Jeon H 외 7
- Anatomy education potential of the first digital twin of a Korean cadaver.
PloS one · 2025-01 · Choi SY, Choi DH, Cho SH 외 2
- Development and application of novel peptide-formulated nanoparticles for treatment of atopic dermatitis.
Journal of materials chemistry. B · 2023-11 · Lim C, Lee S, Shin Y 외 9
- Neurog1-Derived Peptides RMNE1 and DualPep-Shine Penetrate the Skin and Inhibit Melanin Synthesis by Regulating MITF Transcription.
International journal of molecular sciences · 2023-03 · Song EC, Park C, Shin Y 외 3
Patents
KIPRIS · applicant-matchedUS · Published · 2025-03 · Application 19096712
Registered · 2024-10 · Application 1020240144682
Registered · 2024-10 · Application 1020240144681
US · Registered · 2024-03 · Application 18616046
EP · Published · 2023-11 · Application 23892709.9
PCT · Published · 2023-11 · Application PCT/US2023/080419
PCT · Published · 2023-04 · Application PCT/KR2023/004728
US · Registered · 2022-11 · Application 17925608
US · Registered · 2022-11 · Application 17925606
US · Registered · 2022-11 · Application 17925603
Show 34 more patents
EP · Published · 2022-11 · Application 22800565.8
EP · Published · 2022-11 · Application 22800562.5
EP · Published · 2022-11 · Application 22800563.3
PCT · Published · 2022-11 · Application PCT/KR2022/017145
PCT · Published · 2022-11 · Application PCT/KR2022/017148
PCT · Published · 2022-11 · Application PCT/KR2022/017143
PCT · Published · 2022-10 · Application PCT/KR2022/016825
US · Published · 2022-10 · Application 18290572
EP · Published · 2022-10 · Application 22927447.7
PCT · Published · 2022-10 · Application PCT/KR2022/016269
Registered · 2022-08 · Application 1020220108486
US · Published · 2022-05 · Application 18290570
PCT · Published · 2022-05 · Application PCT/KR2022/007344
US · Published · 2022-05 · Application 18288824
EP · Registered · 2022-05 · Application 22807703.8
PCT · Published · 2022-05 · Application PCT/KR2022/006340
Registered · 2022-04 · Application 1020220049727
Registered · 2022-04 · Application 1020220049726
Registered · 2020-07 · Application 1020200086389
Registered · 2020-05 · Application 1020200065406
Registered · 2018-12 · Application 1020180171709
Registered · 2018-12 · Application 1020180171714
Registered · 2018-11 · Application 1020180149902
Registered · 2018-11 · Application 1020180149911
Registered · 2018-11 · Application 1020180149873
Registered · 2018-07 · Application 1020180085903
Registered · 2015-06 · Application 1020150084552
Registered · 2015-06 · Application 1020150082902
Expired · 2015-06 · Application 1020150082181
Rejected · 2014-07 · Application 1020140084819
Expired · 2013-12 · Application 1020130161927
Expired · 2013-12 · Application 1020130161926
Rejected · 2013-10 · Application 1020130130518
Rejected · 2013-10 · Application 1020130130519
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive4
- OpenAIOAI-SearchBot130
- GoogleGoogleOther5
- PerplexityPerplexityBot4
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 25, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for REMEDI Inc. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1992 and KOSDAQ-listed in 2006, VATECH manufactures dental digital X-ray and CT imaging diagnostic devices.
KOSDAQ-listed X-ray imaging solution company with a full lineup of medical, dental, veterinary, and industrial X-ray detectors.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
KOSDAQ-listed dental medical device company offering the RAYSCAN digital diagnostic system and RAYDENT digital treatment solutions.
Genoray, founded in 2001 and KOSDAQ-listed in 2018, manufactures medical and dental X-ray imaging diagnostic devices.
Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.
KOSDAQ-listed digital diagnostic imaging company providing X-ray systems, detectors, and components.
Founded in 2009 and KOSDAQ-listed in 2024, SGHealthcare manufactures X-ray, CT, and MRI medical imaging diagnostic devices.
Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.
Founded in 2001 and KOSDAQ-listed in 2022, Bistos manufactures fetal, neonatal, and patient monitoring medical devices.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition